ARKGvsIGIB
ARK GENOMIC REVOLUTION ETF against iShares 5-10 Year Investment Grade Corporate Bond ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| ARKG | IGIB | |
|---|---|---|
| Expense ratio | 0.75% | 0.040% |
| Assets | $1.4B | $18.6B |
| Net flow, 1 month | — | +$565M |
| Net flow, 1 year | — | +$3.6B |
| Return, YTD | +86.4% | -6.9% |
| Return, 1 year | +81.1% | -7.3% |
| Avg daily volume | 3.9M | 3.8M |
| Holdings | 44 | 2744 |
| Listed | Oct 31, 2014 | Jan 5, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS